» Articles » PMID: 14499791

Physician-reported Reasons for Limited Follow-up of Patients with a Positive Fecal Occult Blood Test Screening Result

Overview
Specialty Gastroenterology
Date 2003 Sep 23
PMID 14499791
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Fecal occult blood testing (FOBT) screening can reduce colorectal cancer (CRC) mortality when patients with an abnormal result [FOBT(+)] undergo a complete diagnostic evaluation (colonoscopy or double-contrast barium enema with or without flexible sigmoidoscopy). The aim of this study was to determine common reasons for nonperformance of a complete diagnostic evaluation.

Methods: We identified 544 FOBT(+) patients, aged 50 yr or older, who had participated in a managed care organization-sponsored CRC screening program. The performance of a complete diagnostic evaluation was determined from a patient-specific follow-up form and managed care organization claims data. Physicians were asked to report whether patients submitted to a complete diagnostic evaluation. When an evaluation was not done, the physicians were also asked to state the reasons for nonperformance.

Results: A total of 248 (46%) patients did not undergo a complete diagnostic evaluation. Physicians provided reasons for nonperformance for 50% (123/248). Factors accounting for nonperformance of a complete diagnostic evaluation were classified as follows: primary care physician decision (50%); specialist decision (28%); patient decision (17%); and other (practice-related) (5%). Many failures to complete an appropriate diagnostic evaluation were due to providers deciding to repeat the FOBT, perform a sigmoidoscopy, or not to proceed with any further testing.

Conclusion: Many patients with a positive FOBT do not receive a complete diagnostic evaluation. The reasons for nonperformance most frequently have to do with physician decision making. Many physician-related explanations do not conform to expert recommendations for appropriate follow-up.

Citing Articles

Comorbidities and Risk Factors of Patients Diagnosed with CRC after Positive Fecal Test in Real Life.

Abu-Freha N, Gouldner R, Cohen B, Gordon M, Sagi O, Taha G Cancers (Basel). 2022; 14(22).

PMID: 36428650 PMC: 9688580. DOI: 10.3390/cancers14225557.


Barriers to completing colonoscopy after a positive fecal occult blood test.

Azulay R, Valinsky L, Hershkowitz F, Elran E, Lederman N, Kariv R Isr J Health Policy Res. 2021; 10(1):11.

PMID: 33573698 PMC: 7879608. DOI: 10.1186/s13584-021-00444-2.


Improved Survival Outcome and Access to Cancer Screening from Hemorrhoid in Patients with Rectal Cancer.

Zou Q, Ren D, Wang X, Bai L, Tang G, Huang M Gastroenterol Res Pract. 2020; 2020:5045142.

PMID: 33381167 PMC: 7749767. DOI: 10.1155/2020/5045142.


Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program.

Green B, Baldwin L, West I, Schwartz M, Coronado G J Prim Care Community Health. 2020; 11:2150132720958525.

PMID: 32912056 PMC: 7488888. DOI: 10.1177/2150132720958525.


Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.

Cusumano V, Corona E, Partida D, Yang L, Yu C, May F BMC Gastroenterol. 2020; 20(1):115.

PMID: 32306919 PMC: 7168865. DOI: 10.1186/s12876-020-01262-7.